羞辱 发表于 2025-3-28 18:16:41
https://doi.org/10.1007/978-3-031-48967-9. With the exception of superficial BCCs, treatment consists of surgery or radiotherapy. A more recent treatment concept for patients with metastastic or unresectable BCCs consists of the use of hedgehog pathway inhibitorsglomeruli 发表于 2025-3-28 19:27:48
Kensuke Sekihara,Srikantan S. Nagarajan overview of the different pathomechanisms and clinical entities of cutaneous drug reactions and their treatments. A particular focus is on type B reactions elicited by chemotherapeutic agents and biological response modifiers used to treat chronic inflammatory and neoplastic diseases.未开化 发表于 2025-3-29 00:34:42
http://reply.papertrans.cn/20/1905/190448/190448_43.png善变 发表于 2025-3-29 04:07:41
Amyloidoses and Hyalinoses,l organs – especially in the skin and mucous membranes. The clinical symptoms of hyalinosis are heterogeneous and vary according to the underlying mutation and age of onset. There are also considerable differences in prognosis. A causal therapy that goes beyond symptomatic treatment is not known.手势 发表于 2025-3-29 07:57:10
http://reply.papertrans.cn/20/1905/190448/190448_45.png集中营 发表于 2025-3-29 14:37:56
http://reply.papertrans.cn/20/1905/190448/190448_46.pngPituitary-Gland 发表于 2025-3-29 15:52:14
http://reply.papertrans.cn/20/1905/190448/190448_47.pngA简洁的 发表于 2025-3-29 23:28:59
http://reply.papertrans.cn/20/1905/190448/190448_48.png昆虫 发表于 2025-3-30 01:40:45
http://reply.papertrans.cn/20/1905/190448/190448_49.png责问 发表于 2025-3-30 07:00:23
Cutaneous Adverse Drug Reactions, overview of the different pathomechanisms and clinical entities of cutaneous drug reactions and their treatments. A particular focus is on type B reactions elicited by chemotherapeutic agents and biological response modifiers used to treat chronic inflammatory and neoplastic diseases.